Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
Conditions: Delirium, Postoperative Interventions: Drug: Liraglutide injection; Drug: Placebo injection Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Study to Evaluate the Safety and Effectiveness of Saxenda ® for Weight Management in Routine Clinical Practice in Taiwan.
Conditions: Obesity Interventions: Drug: Liraglutide Sponsors: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery
Conditions: Weight Loss; Bariatric Surgery Candidate; Obesity, Morbid Interventions: Drug: Liraglutide injection Sponsors: Unidad de Cirugia Bariatrica Hospital Civil Dr. Juan I. Menchaca Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
A Pilot Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
Conditions: Multiple Sclerosis; Long COVID; Long Covid19; Obese; Obesity; Obesity, Morbid; Acute Leukemia in Remission Interventions: Drug: Liraglutide Pen Injector [Saxenda]; Other: Medication Diary Sponsors: University of Chicago Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
Conditions: Multiple Sclerosis; Long COVID; Long Covid19; Obese; Obesity; Obesity, Morbid; Acute Leukemia in Remission Interventions: Drug: Liraglutide Pen Injector [Saxenda]; Other: Medication Diary Sponsors: University of Chicago Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)
Conditions: Type 2 Diabetes Mellitus Interventions: Drug: Canagliflozin; Drug: DPP4 inhibitor; Drug: Liraglutide; Drug: Saxagliptin; Drug: 2nd generation Sulfonylurea Sponsors: AstraZeneca Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome
Condition: Polycystic Ovary Interventions: Drug: liraglutide; Drug: Metformin Sponsor: Beni-Suef University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials
Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility
Conditions: Polycystic Ovary Syndrome; Obesity; Infertility, Female Interventions: Drug: Liraglutide + Metformin; Drug: Metformin Sponsor: Mỹ Đức Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2023 Category: Research Source Type: clinical trials
